nationally notifiable noninfectious conditions and disease outbreaks. This Summary (Noninfectious) is being published in the same volume of MMWR as the annual Summary of Notifiable Infectious Diseases and Conditions (1) . Data on notifiable noninfectious conditions and disease outbreaks from prior years have been published previously (2, 3) .
The Summary (Noninfectious) includes a synopsis of major findings from published surveillance reports for nationally notifiable noninfectious conditions and disease outbreaks, internet links to the complete published surveillance reports, and links to data and tables displaying current and historical descriptive statistics for each condition.
Providing detailed descriptive current year and historical data and tables online makes the data more accessible and usable to the public. Surveillance summaries and other published reports on each condition will now present major statistical findings and trends and summarize what public health programs are doing to address the condition, evidence-based recommendations for prevention and control of the condition, and how persons, workers, and community groups can use the combination of information to improve their health. An additional benefit of these changes is that the CDC programs responsible for noninfectious conditions and disease outbreaks will develop and publish reports for each notifiable condition as the data become available. This approach minimizes delays that can occur when collating data from multiple programs into a single report. This Summary (Noninfectious) presents the highlights of surveillance information published between April 1, 2016 and January 31, 2017 (surveillance period varied) on five of nine nationally notifiable noninfectious conditions 1 Although the sources of data for nationally notifiable infectious diseases and for nationally notifiable noninfectious conditions and disease outbreaks are the same (i.e., local, state, and territorial jurisdictions' data on reportable conditions) and have the same general purpose (i.e., monitoring and responding to the condition to improve population health), a number of differences should be considered when comparing findings across conditions and by time, location, and demographic characteristic (4) (5) (6) (7) (8) (9) (10) (11) (12) (13) (14) . Under-reporting of noninfectious conditions and disease outbreaks to local and state health departments occurs, and the completeness of reporting, and therefore of notifications to CDC, varies by condition (4) (5) (6) (7) (8) (9) (10) (11) (12) (13) (14) . Moreover, variations in data collection methods also influence comparative observations across conditions and disease outbreaks. For example, case-based surveillance of acute pesticide-related illness or injury, elevated blood lead levels, and cancer is focused on collecting information on cases that meet the criteria specified in national condition-specific case definitions and on collecting information about those persons' conditions. In contrast, surveillance of outbreaks of foodborne and waterborne illness seeks to identify clusters of sick persons with a common exposure (as opposed to persons with a specific disease).
Foodborne disease outbreaks are defined as two or more cases of similar illness resulting from common ingestion of a food. Waterborne disease outbreaks are defined as two or more cases of a similar illness resulting from common exposure to water or water-associated chemicals (https://wwwn.cdc.gov/nndss/conditions/notifiable /2014/outbreaks (https://wwwn.cdc.gov/nndss/conditions/notifiable/2014/outbreaks)). For these conditions, information is collected about the characteristics of the disease outbreaks, including data from epidemiologic and environmental investigations.
Even among conditions for which case-based surveillance methods are used, substantial variation exists. For example, for elevated blood lead levels, laboratory findings are used to identify persons who have been exposed to a hazard but clinical diagnosis of lead poisoning is not required to be counted as a case. In contrast, for many other conditions, a diagnosis based on clinical and/or pathological criteria is needed to meet the case definition for a notification to CDC (https://wwwn.cdc.gov/nndss/conditions/notifiable/2014/non-infectious-conditions (https://wwwn.cdc.gov/nndss/conditions/notifiable/2014/non-infectious-conditions)).
The date of the occurrence of the condition is defined differently among the conditions. For cancer, as for some infectious diseases, including tuberculosis and human immunodeficiency virus infection, the date of occurrence is assigned on the basis of the date that the condition is diagnosed. For silicosis, the date of occurrence represents the date of the initial report (e.g., the date of a hospital discharge report, clinician report, or a workers' compensation claim). For lead screening test results, the date of occurrence is the date that the sample was tested. For acute pesticide-related illness, the date of occurrence is the date of pesticide exposure, which generally is identical to the date of symptom onset because symptom onset typically occurs within seconds to hours of exposure. For disease outbreaks, the date of occurrence represents the date of the illness onset of the first case in the outbreak.
The sources and definitions of race and ethnicity also vary over time and among conditions. For example, information about race and ethnicity for lead exposure is based on self-report. However, for cancer incidence, it is based on medical records, which might not be based on self-report, or from matching the names of persons with cancer with lists of surnames for different ethnic groups or with tribal registries. For silicosis, race and ethnicity are based on self-report, report from next-of-kin, or from medical records. Race-and ethnicity-specific information among the conditions also might vary depending on the jurisdictions' systems for submitting notifications to CDC and the need to protect private health information.
There are also variations across conditions in terms of which specific U.S. Census Bureau data sets were used to Public health surveillance of acute nonoccupational and occupational pesticide-related illness and injury serves a vital societal role by enabling CDC and public health authorities to assess the magnitude and characteristics of this condition. Tracking the associated health effects of pesticides can help ensure that no pesticides pose an unreasonable burden (8) . Using surveillance data collected between 1998 and 2015, CDC documented illness and injury for four different pesticides (9) (10) (11) . The magnitude, characteristics, and root causes for acute paraquat-and diquat-related illnesses identified in the United States during 1998-2011 were reported (9) . At the time these data on paraquat-and diquat-related illnesses were analyzed, 2011 was the most recent year with complete data.
Although the magnitude of acute paraquat-and/or diquat-related illnesses reported to CDC by state agencies was relatively low (300 paraquat-and 144 diquat-related acute illnesses were identified), 29 fatalities were identified.
Nineteen paraquat-related deaths were due to ingestion, seven of which were unintentional, often due to improper storage in beverage bottles. Soon after this report was published, the U.S. Environmental Protection Agency (EPA), the federal agency responsible for regulating pesticides (7USC §136), announced interim risk mitigation actions to address the root causes for paraquat-related acute illnesses identified by CDC, which were finalized in December 2016 (12) . These actions include requiring stronger warnings on paraquat product labels, developing improved training courses that must be taken by all paraquat applicators, and re-engineering all paraquat containers to use closed system technology when mixing and loading paraquat (closed systems are devices designed to prohibit the escape of the pesticide outside the system, thereby preventing exposure to a handler).
CDC acute pesticide-related illness and injury surveillance data identified a family that was poisoned by sulfuryl fluoride, a highly toxic pesticide (10). In August 2015, a family of five in Florida was exposed to sulfuryl fluoride after their house was fumigated to eradicate termites. * All family members had minor symptoms, except a son aged 9 years who was hospitalized for 39 days for basal ganglia injury. Several violations were committed by the pest control company responsible for the fumigation, including failure to have functioning measuring devices to ensure that sulfuryl fluoride concentrations had declined to safe levels before allowing the family to return home.
Illnesses related to exposure to dimethyl disulfide (DMDS) that occurred in 2014 have been described (11) . DMDS is a relatively new soil fumigant that is considered a replacement for methyl bromide. Methyl bromide is being phased out because it is depleting the stratospheric ozone layer (13). Compared with DMDS, methyl bromide is also more acutely toxic to human health and has the potential to produce severe illness and death (11, 14) . In 2014, a total of 43 cases of DMDS-related illness were identified in Florida, (87%) of which were classified as having low severity illness (i.e., illnesses that usually resolve quickly without treatment) and 12% were classified as having moderate severity (i.e., illnesses that require medical treatment but are not life-threatening and result in <6 days lost from work or normal activities) (15). All of the DMDS-related cases were nonoccupational and involved exposure to off-target drift of DMDS that had been applied to neighboring strawberry farms. DMDS has a sulfurous odor similar to that of garlic and decaying fish, and the odor can be detected at concentrations thought to be nontoxic. Some reported symptoms (e.g., headache and nausea) might have resulted from aversion to the odor.
Improved methods of preventing off-target movement of DMDS to neighboring communities are needed.
Additional mitigation when DMDS applications are planned is to notify nearby community members about the upcoming application and provide them with advice on appropriate actions to be taken if they detect DMDS odor (16). The root causes identified in at least two of the CDC reports (9,10) are addressed by new rules finalized and announced by EPA in December 2016. These rules are intended to improve the training and certification of pesticide applicators to ensure competence when using the riskiest pesticides (i.e. "restricted use" pesticides that can be purchased only by trained and certified pesticide applicators) (17). This is the first major revision to these rules in approximately 40 years. The proposed new rules will provide health benefits to pesticide applicators, Center for Chronic Disease Prevention and Health Promotion, CDC * In home fumigations, the home to be fumigated usually is covered with a tarp or tent and sealed completely before releasing the sulfuryl fluoride gas. Chloropicrin, which has a strong odor and is highly irritating, is added to the odorless sulfuryl fluoride gas fumigant as a "warning agent" that encourages persons to vacate an area before being exposed to a lethal dose of the sulfuryl fluoride fumigant. Pesticide applicators post warning signs around the building notifying perssons to keep out. After the home is fumigated for a set period of time (range: 2-72 hours), the tarp is removed and the structure is aerated by the use of fans. Pest control operators are required to measure the level of sulfuryl fluoride remaining in the living space to ensure that it is below the EPA-approved concentration before occupants are allowed to reenter.
